Cargando…

Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis

Primary sclerosing cholangitis (PSC) is a rare chronic cholestatic liver disease characterized by multifocal bile duct strictures. To date, underlying molecular mechanisms of PSC remain unclear, and therapeutic options are limited. METHODS: We performed cell-free messenger RNA (cf-mRNA) sequencing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalasani, Naga, Vuppalanchi, Raj, Lammert, Craig, Gawrieh, Samer, Braun, Jerome V., Zhuang, Jiali, Ibarra, Arkaitz, Ross, David A., Nerenberg, Michael, Quake, Stephen R., Sninsky, John J., Toden, Shusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208702/
https://www.ncbi.nlm.nih.gov/pubmed/37219869
http://dx.doi.org/10.1097/HC9.0000000000000140
_version_ 1785046726514573312
author Chalasani, Naga
Vuppalanchi, Raj
Lammert, Craig
Gawrieh, Samer
Braun, Jerome V.
Zhuang, Jiali
Ibarra, Arkaitz
Ross, David A.
Nerenberg, Michael
Quake, Stephen R.
Sninsky, John J.
Toden, Shusuke
author_facet Chalasani, Naga
Vuppalanchi, Raj
Lammert, Craig
Gawrieh, Samer
Braun, Jerome V.
Zhuang, Jiali
Ibarra, Arkaitz
Ross, David A.
Nerenberg, Michael
Quake, Stephen R.
Sninsky, John J.
Toden, Shusuke
author_sort Chalasani, Naga
collection PubMed
description Primary sclerosing cholangitis (PSC) is a rare chronic cholestatic liver disease characterized by multifocal bile duct strictures. To date, underlying molecular mechanisms of PSC remain unclear, and therapeutic options are limited. METHODS: We performed cell-free messenger RNA (cf-mRNA) sequencing to characterize the circulating transcriptome of PSC and noninvasively investigate potentially bioactive signals that are associated with PSC. Serum cf-mRNA profiles were compared among 50 individuals with PSC, 20 healthy controls, and 235 individuals with NAFLD. Tissue and cell type-of-origin genes that are dysregulated in subjects with PSC were evaluated. Subsequently, diagnostic classifiers were developed using PSC dysregulated cf-mRNA genes. RESULTS: Differential expression analysis of the cf-mRNA transcriptomes of PSC and healthy controls resulted in identification of 1407 dysregulated genes. Furthermore, differentially expressed genes between PSC and healthy controls or NAFLD shared common genes known to be involved in liver pathophysiology. In particular, genes from liver- and specific cell type-origin, including hepatocyte, HSCs, and KCs, were highly abundant in cf-mRNA of subjects with PSC. Gene cluster analysis revealed that liver-specific genes dysregulated in PSC form a distinct cluster, which corresponded to a subset of the PSC subject population. Finally, we developed a cf-mRNA diagnostic classifier using liver-specific genes that discriminated PSC from healthy control subjects using gene transcripts of liver origin. CONCLUSIONS: Blood-based whole-transcriptome cf-mRNA profiling revealed high abundance of liver-specific genes in sera of subjects with PSC, which may be used to diagnose patients with PSC. We identified several unique cf-mRNA profiles of subjects with PSC. These findings may also have utility for noninvasive molecular stratification of subjects with PSC for pharmacotherapy safety and response studies.
format Online
Article
Text
id pubmed-10208702
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102087022023-05-25 Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis Chalasani, Naga Vuppalanchi, Raj Lammert, Craig Gawrieh, Samer Braun, Jerome V. Zhuang, Jiali Ibarra, Arkaitz Ross, David A. Nerenberg, Michael Quake, Stephen R. Sninsky, John J. Toden, Shusuke Hepatol Commun Original Article Primary sclerosing cholangitis (PSC) is a rare chronic cholestatic liver disease characterized by multifocal bile duct strictures. To date, underlying molecular mechanisms of PSC remain unclear, and therapeutic options are limited. METHODS: We performed cell-free messenger RNA (cf-mRNA) sequencing to characterize the circulating transcriptome of PSC and noninvasively investigate potentially bioactive signals that are associated with PSC. Serum cf-mRNA profiles were compared among 50 individuals with PSC, 20 healthy controls, and 235 individuals with NAFLD. Tissue and cell type-of-origin genes that are dysregulated in subjects with PSC were evaluated. Subsequently, diagnostic classifiers were developed using PSC dysregulated cf-mRNA genes. RESULTS: Differential expression analysis of the cf-mRNA transcriptomes of PSC and healthy controls resulted in identification of 1407 dysregulated genes. Furthermore, differentially expressed genes between PSC and healthy controls or NAFLD shared common genes known to be involved in liver pathophysiology. In particular, genes from liver- and specific cell type-origin, including hepatocyte, HSCs, and KCs, were highly abundant in cf-mRNA of subjects with PSC. Gene cluster analysis revealed that liver-specific genes dysregulated in PSC form a distinct cluster, which corresponded to a subset of the PSC subject population. Finally, we developed a cf-mRNA diagnostic classifier using liver-specific genes that discriminated PSC from healthy control subjects using gene transcripts of liver origin. CONCLUSIONS: Blood-based whole-transcriptome cf-mRNA profiling revealed high abundance of liver-specific genes in sera of subjects with PSC, which may be used to diagnose patients with PSC. We identified several unique cf-mRNA profiles of subjects with PSC. These findings may also have utility for noninvasive molecular stratification of subjects with PSC for pharmacotherapy safety and response studies. Lippincott Williams & Wilkins 2023-05-23 /pmc/articles/PMC10208702/ /pubmed/37219869 http://dx.doi.org/10.1097/HC9.0000000000000140 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Article
Chalasani, Naga
Vuppalanchi, Raj
Lammert, Craig
Gawrieh, Samer
Braun, Jerome V.
Zhuang, Jiali
Ibarra, Arkaitz
Ross, David A.
Nerenberg, Michael
Quake, Stephen R.
Sninsky, John J.
Toden, Shusuke
Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis
title Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis
title_full Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis
title_fullStr Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis
title_full_unstemmed Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis
title_short Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis
title_sort circulating cell-free messenger rna secretome characterization of primary sclerosing cholangitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208702/
https://www.ncbi.nlm.nih.gov/pubmed/37219869
http://dx.doi.org/10.1097/HC9.0000000000000140
work_keys_str_mv AT chalasaninaga circulatingcellfreemessengerrnasecretomecharacterizationofprimarysclerosingcholangitis
AT vuppalanchiraj circulatingcellfreemessengerrnasecretomecharacterizationofprimarysclerosingcholangitis
AT lammertcraig circulatingcellfreemessengerrnasecretomecharacterizationofprimarysclerosingcholangitis
AT gawriehsamer circulatingcellfreemessengerrnasecretomecharacterizationofprimarysclerosingcholangitis
AT braunjeromev circulatingcellfreemessengerrnasecretomecharacterizationofprimarysclerosingcholangitis
AT zhuangjiali circulatingcellfreemessengerrnasecretomecharacterizationofprimarysclerosingcholangitis
AT ibarraarkaitz circulatingcellfreemessengerrnasecretomecharacterizationofprimarysclerosingcholangitis
AT rossdavida circulatingcellfreemessengerrnasecretomecharacterizationofprimarysclerosingcholangitis
AT nerenbergmichael circulatingcellfreemessengerrnasecretomecharacterizationofprimarysclerosingcholangitis
AT quakestephenr circulatingcellfreemessengerrnasecretomecharacterizationofprimarysclerosingcholangitis
AT sninskyjohnj circulatingcellfreemessengerrnasecretomecharacterizationofprimarysclerosingcholangitis
AT todenshusuke circulatingcellfreemessengerrnasecretomecharacterizationofprimarysclerosingcholangitis